The Potential Additional Benefit of Infliximab in Patients With Chronic Pulmonary Sarcoidosis Already Receiving Corticosteroids: A Retrospective Analysis From a Randomized Clinical Trial
Respiratory Medicine - United Kingdom
doi 10.1016/j.rmed.2013.11.019
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Elsevier BV